06 Aug

Jennifer Duff is the Global R&D Operations lead for the Accenture Life Sciences practice as well as a Sales and Account Lead in the Accenture Life Sciences North America Operations practice, currently overseeing operations for a major pharma client. She has over 21 years of experience in the…

06 Aug

François holds a Master in Business Administration from the ICHEC School of Management, Brussels, Belgium. Over the past 20 years in the pharmaceutical industry, he has held positions as statistical programmer, SAS and JAVA developer and IT project leader for companies such as GSK, UCB and IDDI. During…

06 Aug

Demetris is currently VP and Global Head of Data Monitoring and Management at Pfizer. Demetris started his career as a Laboratory Scientist in 1991 at Schering Plough Research Institute. He transitioned into the Clinical Development space and held roles of increasing responsibilities in Trial Management and Monitoring and…

06 Aug

Mr. Nadolny is a pragmatic leader focusing on technology, innovation, strategic planning, change management, and the setup of new capabilities. Mr. Nadolny is currently the Global head of Clinical Data Management and Programming at Allergan. In his role, Patrick also leads change management initiatives in the field system…

11 Jun

As Chief Business Officer, Jonathan Andrus leads Clinical Ink’s solution management & compliance teams to help sponsors and CROs better leverage eSource, eCOA and ePRO data. With 20+ years of experience, Mr. Andrus brings extensive expertise developing eClinical services that integrate data and technology to help life science…

11 Jun

Lisbeth has been a GCP and pharmacovigilance inspector at the Danish Health and Medicines Authority since 2006. Prior to that, she has experience from the authority perspective on regulatory affairs and as an assessor of clinical trial protocols (1993-1999), from a research and hospital perspective (Clinical pharmacology at…

11 Jun

Ni Aye Khin

  • By panos

Ni A. Khin, M.D., is Director of Division of Clinical Compliance Evaluation, within Office of Scientific Investigations (OSI), Office of Compliance, Center for Drug Evaluation and Research, at FDA. In this position, she provides scientific oversight for CDER-assigned bioresearch monitoring (BIMO) activities including compliance programs of clinical investigators,…

11 Jun

Kassa Ayalew, M.D., M.P.H., serves as Branch Chief for Good Clinical Practice Assessment Branch at the Division of Clinical Compliance Evaluation in the Office of Scientific Investigation at Center for Drug Evaluation and Research (CDER) in FDA. Dr. Ayalew oversees verification of the integrity of efficacy and safety…

11 Jun

Dr. Mulinde is currently the Senior Policy Advisor for the Division of Clinical Compliance Evaluation in the Office of Scientific Investigations, CDER, FDA.  Prior to joining the Office of Scientific Investigations, she was a Clinical Team Leader in the Division of Anti-Infective Products in CDER’s Office of New…

11 Jun

Kent Thoelke is the Chief Scientific Officer and Executive Vice President of PRA Health Sciences.  With over 28 years in the drug development and clinical trials industry, Mr. Thoelke has had the opportunity to participate in all levels of drug research from the bench to the bedside globally. …